Overexpression of cellular RhoGDI1 increased resistance to etoposide- and doxorubicin-induced apoptosis in breast and lymphoma cells, and depletion of RhoGDI1 had the opposite effect. The gene discussed is ARHGDIA; the disease is lymphoma.